Projektergebnisse 2022
European Pharmaceutical Market: Guide Explains Top Five Countries
25.06.18 – The five largest EU countries dominate two thirds of the European pharmaceutical market. Market conditions in these Member States differ substantially and present challenges for pharmaceutical companies. A new IGES Group publication now provides support in this matter. » Details
New information about access to the German healthcare market
19.02.18 – Current brochures provide information about access to the German healthcare market. They are especially directed at international developers of novel pharmaceuticals and medical devices. The publications, authored by IGES Group experts, provide an overview of the reimbursement regulations for new treatment methods. » Details
Higher sickness absence rates in Berlin and Brandenburg compared to the average German population
13.01.18 – In 2013, sickness absence in Berlin-Brandenburg led to production losses of approximately three million euros. Musculoskeletal disorders accounted for the highest number of days of absence, both in this region and nationwide, followed by respiratory diseases. » Details
